Adam DeVito spent decades shaping how Americans eat, from French kitchens to one of the most successful new product launches in fifty years. His latest project, Monj Health, has just joined forces with Tampa-based Precision Telemed to deliver what GLP-1 medicine has been missing.

United States, 16th Jun 2026 – Most people who work in food never get within reach of one billion dollars, let alone seven. Adam DeVito has built his career at that scale, and he has spent the last decade trying to use what he learned to fix something that almost everyone in healthcare quietly admits is broken: how we eat. 

DeVito began in top French kitchens in the United States and France. He went on to own restaurants, open two schools for professional chefs, and co-author eleven internationally distributed books on healthy cooking. From there he was invited to Kraft Foods as the first Executive Chef and Head of New Concept Development at what was then the largest food company in the world. His team brought hundreds of new and reformulated products to market, including the creation of a multi-billion-dollar brand that became the most successful new product launch in fifty years. 

After Kraft, DeVito spent ten years as Managing Partner at Sterling-Rice Group in Boulder, leading health and wellness strategy for nearly every major organic and natural foods brand in the country. Along the way, working with renowned game expert Dr. Jane McGonigal on SuperBetter, he became convinced of something most of his industry had ignored: behavior change rooted in intrinsic inspiration, the desire to live well, lasts longer than behavior change rooted in pressure, fear, or shame. 

That conviction became Monj Health. 

This week, Monj Health and Precision Telemed announced a partnership that brings DeVito’s life work directly into GLP-1 care. The result is called the Advanced Metabolic Program, and it represents the first time DeVito’s nutrition and behavior platform has been embedded inside a compounded telehealth practice in the United States. 

Why GLP-1 Care Needed Him 

GLP-1 medications like compounded semaglutide and tirzepatide have rewritten what is possible in weight loss. They also leave a gap. Research published in The BMJ in January 2026 found that patients regain weight at roughly 0.4 kilograms per month after stopping the medication, returning to baseline within about two years. A separate review published in The Lancet found that approximately 50 to 60 percent of lost weight is regained within twelve months of cessation, with cardiometabolic improvements reversing alongside it. 

The clinical consensus on what to do about this is unusually clear. A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society, released in 2025, recommends that GLP-1 therapy be paired with structured nutritional and behavioral support, including muscle-preserving protein intake, culinary skill building, and lifestyle integration that patients can carry forward after the prescription ends. 

Almost no one is actually doing this. That is the gap Precision Telemed and Monj are now filling together. 

“The healthcare system has given people powerful tools and then left them completely without the knowledge to use them,” DeVito said. “Food is the missing piece. Monj is the bridge between what the medication can do and what your life can actually look like.” 

What the Program Looks Like for Patients 

Patients in the Advanced Metabolic Program continue to receive their compounded GLP-1 medication through Precision Telemed, prescribed and managed by licensed clinicians through the company’s telehealth platform. Monj Health adds a structured layer around that prescription, including live cooking classes built around practical, satiating meals, a four-phase metabolic plan that moves patients from Reset to Nourish to Maintain to Sustain, habit-building tools rooted in self-determination theory, and ongoing coaching that adapts as the patient’s needs change. 

The design choice is deliberate. Rather than treating food as a separate concern that patients are expected to figure out alone, the program integrates clinical care, nutrition education, and behavioral coaching into a single experience. The aim is straightforward: more durable results, better quality of life on the medication, and a real plan for what happens when the dose comes down. 

A New Standard 

For a company built on compounded GLP-1 care, partnering with a chef-led behavior platform is an unusual move. It is also, the leadership team believes, where the field is heading. 

“Our patients are not failing the medication. The medication is doing exactly what it is supposed to do,” the Precision Telemed spokesperson said. “What has been missing is the part of care that lives outside the pharmacy. That is what we have built with Monj, and we believe it is going to change what people can expect from a telehealth weight loss program.” 

Full enrollment details for the Advanced Metabolic Program are rolling out across Precision Telemed’s semaglutide and tirzepatide treatment pages in the coming weeks. 

About Adam DeVito 

Adam DeVito is the founder and CEO of Monj Health. He is the co-author of eleven internationally distributed books on healthy cooking, the founder of two schools for professional chefs, and the original founder of one of the most successful packaged food brands of the last half century. He served as the first Executive Chef and Head of New Concept Development at Kraft Foods and spent a decade as Managing Partner of Sterling-Rice Group, one of the country’s leading strategy and innovation firms in food, health, and wellness. 

About Precision Telemed 

Precision Telemed is a Tampa, Florida based telehealth provider offering compounded semaglutide, compounded tirzepatide, microdose GLP-1 and GLP-1 GIP protocols, sermorelin, testosterone, and NAD therapies. The company operates a HIPAA compliant platform and is LegitScript certified. All medications are dispensed through State Board of Pharmacy licensed sterile compounding pharmacies and FDA licensed 503(b) outsourcing facilities.

Media Contact

Organization: Precision Telemed

Contact Person: Carlie Cannon

Website: https://precisiontelemed.com/

Email: Send Email

Address:Tampa, Florida

Country:United States

Release id:46032

The post The Chef Who Built a Multi-Billion-Dollar Brand at Kraft Now Wants to Help GLP-1 Patients Keep the Weight Off appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section